Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al

Late and booster anti‐SARS‐CoV‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al

Bibliographic Details
Main Authors:	Athanasios‐Dimitrios Bakasis, Andreas V. Goules, Panayiotis G. Vlachoyiannopoulos, Kleopatra Bitzogli, Athanasios G. Tzioufas
Format:	Article
Language:	English
Published:	Wiley 2022-08-01
Series:	ACR Open Rheumatology
Online Access:	https://doi.org/10.1002/acr2.11446

Similar Items

Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases
by: Athanasios-Dimitrios Bakasis, et al.
Published: (2022-01-01)

Small airways dysfunction in patients with systemic sclerosis and interstitial lung disease
by: Panagiotis K. Panagopoulos, et al.
Published: (2022-11-01)

Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study
by: Georgios Boutzios, et al.
Published: (2023-06-01)

Occurrence and Antigenic Specificity of Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (P-ANCA) in Systemic Autoimmune Diseases
by: Ourania D. Argyropoulou, et al.
Published: (2021-08-01)

Responders and nonresponders to pharmacotherapy and allergen immunotherapy
by: Marek Jakalski, et al.
Published: (2019-12-01)

Predisposing Factors, Clinical Picture, and Outcome of B-Cell Non-Hodgkin’s Lymphoma in Sjögren’s Syndrome
by: Ioanna E. Stergiou, et al.
Published: (2022-10-01)

Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
by: Corrado Campochiaro, et al.
Published: (2024-04-01)

Troubleshooting a Nonresponder: Guidance for the Strength and Conditioning Coach
by: Benjamin H. Gleason, et al.
Published: (2021-06-01)

A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids
by: Agnieszka Ewa Sieradzka, et al.
Published: (2022-07-01)

On- and off-label use of rituximab in rheumatic diseases
by: Gilda Sandri, et al.
Published: (2021-04-01)

Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease–Associated Interstitial Lung Disease
by: Lisa Zhu, et al.
Published: (2021-01-01)

Analysis of the Influencing Factors of Immunological Nonresponders in Wuhan, China
by: Enze Lei, et al.
Published: (2022-01-01)

Short‐term GAA loading: Responders versus nonresponders analysis
by: Sergej M. Ostojic
Published: (2020-08-01)

Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?
by: Athanasios-Dimitrios Bakasis, et al.
Published: (2021-05-01)

Rituximab for rheumatic diseases in children: Results of a retrospective study of the safety of therapy
by: M. I. Kaleda, et al.
Published: (2021-05-01)

Responders and nonresponders to topical capsaicin display distinct temporal summation of pain profiles
by: Felyx Wong, et al.
Published: (2023-06-01)

Effect of vamana in chronic autoimmune urticaria: A nonresponding case to steroids and cyclosporine
by: Pushpa Sharma, et al.
Published: (2018-01-01)

General Index to volumes I-XXX
by: Besterman, T, et al.
Published: (2017)

XXX : a novelization /
by: Odom, Mel, 1950-, et al.
Published: (2002)

Linguistica XVI-XXX
by: Gordana Vitorović
Published: (1990-12-01)

Current Insights into Tissue Injury of Giant Cell Arteritis: From Acute Inflammatory Responses towards Inappropriate Tissue Remodeling
by: Dimitris Anastasios Palamidas, et al.
Published: (2024-02-01)

Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster
by: Montserrat Torres, et al.
Published: (2022-11-01)

<i>Helicobacter pylori</i> Eradication Reverses DNA Damage Response Pathway but Not Senescence in Human Gastric Epithelium
by: Polyxeni Kalisperati, et al.
Published: (2024-03-01)

Mycophenolate mofetil and atherosclerosis
by: Z S Alekberova, et al.
Published: (2009-10-01)

Role of thymosin α1 in restoring immune response in immunological nonresponders living with HIV
by: Chaoyu Chen, et al.
Published: (2024-01-01)

Linking Federal Administrative Records to Respondents and Nonrespondents in Household Surveys: A Case Study
by: Joseph Sakshaug, et al.
Published: (2017-04-01)

What They Are Not Telling Us: Analysis of Nonresponders on a National Survey of Resident Well-Being
by: Chelsea F. Cardell, MD, MS, et al.
Published: (2022-12-01)

Low intensity extracorporeal shockwave Therapy shifts PDE5i nonresponders to responders
by: Jiamin Wang, et al.
Published: (2020-09-01)

SARS-CoV-2 Humoral Immunity Persists Following Rituximab Therapy
by: Liangjian Lu, et al.
Published: (2023-12-01)

Studia theodisca XXX (2023)
by: Fausto Cercignani
Published: (2023-11-01)

Studia austriaca XXX (2022)
by: Fausto Cercignani
Published: (2022-06-01)

XXX_LIVE_NUDE_GIRLS!!!
by: Jennifer Walshe
Published: (2022-09-01)

Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial.
by: Tolin, D, et al.
Published: (2004)

Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases
by: Maria De Santis, et al.
Published: (2022-05-01)

Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort
by: Eric Hachulla, et al.
Published: (2022-09-01)

Triploidía (69 xxx): reporte de caso
by: A. Giraldo, et al.
Published: (2018-06-01)

Rituximab and COVID-19 infection in patients with autoimmune rheumatic diseases – A real-world study from India
by: Aswin M Nair, et al.
Published: (2023-01-01)

Mycophenolate mofetil and mycophenolic acid for the treatment of eosinophilic fasciitis: report of two cases and literature review
by: Ilse Andrea Moreno-Arquieta, et al.
Published: (2022-04-01)

Mycophenolate mofetil–induced hyperlipidemia with cutaneous manifestations
by: Rebecca M. Yim, et al.
Published: (2023-03-01)

Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
by: Sotirios G. Papageorgiou, et al.
Published: (2022-04-01)